Fulgent Genetics (FLGT) Gains from Investment Securities (2015 - 2026)
Fulgent Genetics (FLGT) posted Gains from Investment Securities of $210000.0 for Q1 2026, down 62.37% sequentially from $558000.0 in Q4 2025, and up 1100.0% YoY from $17500.0 in Q1 2025.
Fulgent Genetics (FLGT) Gains from Investment Securities (2015 - 2026) Analysis & Trends
Fulgent Genetics (FLGT) has 12 years of Gains from Investment Securities data on file, last reported at $210000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 1100.0% year-over-year to $210000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 46.97% YoY) and the FY2025 annual result came in at $700000.0, down 38.7% from the prior year.
- Gains from Investment Securities slipped to $210000.0 in Q1 2026 per FLGT's latest filing, from $558000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $558000.0 in Q4 2025, with the low at -$2.1 million in Q4 2024.
- Average Gains from Investment Securities over 5 years is -$100529.4, with a median of $18000.0 recorded in 2024.
- Year-over-year, Gains from Investment Securities jumped 12250.0% in 2022 and slumped 1631.16% in 2024.
- Fulgent Genetics' Gains from Investment Securities stood at -$744000.0 in 2022, then surged by 118.55% to $138000.0 in 2023, then tumbled by 1631.16% to -$2.1 million in 2024, then surged by 126.41% to $558000.0 in 2025, then sank by 62.37% to $210000.0 in 2026.
- Business Quant data shows FLGT's Gains from Investment Securities at $210000.0 in Q1 2026, $558000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Fulgent Genetics | 642.94 Mn | 360.99 Mn | 21.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 558,000.00 |
| Dec 31, 2025 | 558,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -2.11 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Sep 30, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | -580,000.00 |
| Mar 31, 2024 | -580,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Dec 31, 2023 | 138,000.00 |